Submitted by
Dividend Yield
as part of our
contributors program
.
Healthcare Dividend Stocks With Highest Expected EPS Growth
Researched By "
long-term-investments.blogspot.com
". I like healthcare companies because the sector is a long-term
growth area due to the ongoing aging population. The sector is a
46.1 trillion bet on stronger than expected health diseases with a
current dividend yield of 3.20 percent. We know that the sector is
very political driven because heath is a question of cost and
money. 80 percent of the world's population cannot finance a solid
medical-aid, medical-care ore even an old-care. The best dividend
stocks within the sector still come from the major drug
manufacturing industry as well as from the medical practitioners
industry.
I made a little screen of the best large capitalized stocks with
the highest expected earnings per share growth for the next five
years. The industry with the biggest earnings forecast is
definitely the biotechnology industry, followed by medical
appliances and equipment stocks. But those companies pay no
dividends. I focused on stocks with a positive yield and a
double-digit earnings growth. Finally, fourteen companies remained
of which all are currently recommended to buy. The mostly
represented companies are from the healthcare plans industry.
Here are my favorite stocks:
WellPoint (
WLP
)
has a market capitalization of $20.07 billion. The company employs
37,700 people, generates revenue of $60.71 billion and has a net
income of $2.65 billion. The firm's earnings before interest,
taxes, depreciation and amortization (EBITDA) amounts to $4.72
billion. The EBITDA margin is 7.78 percent (the operating margin is
6.52 percent and the net profit margin 4.36 percent).
Financial Analysis: The total debt represents 18.83 percent of
the company's assets and the total debt in relation to the equity
amounts to 42.06 percent. Due to the financial situation, a return
on equity of 11.24 percent was realized. Twelve trailing months
earnings per share reached a value of $7.32. Last fiscal year, the
company paid $1.00 in the form of dividends to shareholders. The
earnings per share are expected to grow by 10.10 percent yearly
over the next five years.
Market Valuation: Here are the price ratios of the company: The
P/E ratio is 8.43, the P/S ratio is 0.33 and the P/B ratio is
finally 0.90. The dividend yield amounts to 1.86 percent and the
beta ratio has a value of 0.95.
Novo Nordisk (
NVO
)
has a market capitalization of $102.86 billion. The company employs
33,501 people, generates revenue of $11.51 billion and has a net
income of $2.97 billion. The firm's earnings before interest,
taxes, depreciation and amortization (EBITDA) amounts to $4.31
billion. The EBITDA margin is 37.48 percent (the operating margin
is 33.72 percent and the net profit margin 25.77 percent).
Financial Analysis: The total debt represents 1.32 percent of
the company's assets and the total debt in relation to the equity
amounts to 2.28 percent. Due to the financial situation, a return
on equity of 45.95 percent was realized. Twelve trailing months
earnings per share reached a value of $6.38. Last fiscal year, the
company paid $2.43 in the form of dividends to shareholders. The
earnings per share are expected to grow by 16.45 percent yearly
over the next five years. The company has the biggest eps growth
forecast of all healthcare dividend stocks.
Market Valuation: Here are the price ratios of the company: The
P/E ratio is 24.81, the P/S ratio is 6.21 and the P/B ratio is
finally 13.52. The dividend yield amounts to 1.59 percent and the
beta ratio has a value of 0.55.
UnitedHealth Group (
UNH
)
has a market capitalization of $58.17 billion. The company employs
99,000 people, generates revenue of $101.86 billion and has a net
income of $5.14 billion. The firm's earnings before interest,
taxes, depreciation and amortization (EBITDA) amounts to $9.59
billion. The EBITDA margin is 9.41 percent (the operating margin is
8.31 percent and the net profit margin 5.05 percent).
Financial Analysis: The total debt represents 17.14 percent of
the company's assets and the total debt in relation to the equity
amounts to 41.14 percent. Due to the financial situation, a return
on equity of 19.00 percent was realized. Twelve trailing months
earnings per share reached a value of $5.25. Last fiscal year, the
company paid $0.61 in the form of dividends to shareholders. The
earnings per share are expected to grow by 11.20 percent yearly
over the next five years.
Market Valuation: Here are the price ratios of the company: The
P/E ratio is 10.84, the P/S ratio is 0.57 and the P/B ratio is
finally 2.09. The dividend yield amounts to 1.49 percent and the
beta ratio has a value of 0.93.
Zimmer Holdings (
ZMH
)
has a market capitalization of $11.45 billion. The company employs
8,500 people, generates revenue of $4.45 billion and has a net
income of $760.00 million. The firm's earnings before interest,
taxes, depreciation and amortization (EBITDA) amounts to $1.38
billion. The EBITDA margin is 31.09 percent (the operating margin
is 23.00 percent and the net profit margin 17.07 percent).
Financial Analysis: The total debt represents 20.19 percent of
the company's assets and the total debt in relation to the equity
amounts to 31.22 percent. Due to the financial situation, a return
on equity of 13.49 percent was realized. Twelve trailing months
earnings per share reached a value of $4.28. Last fiscal year, the
company paid no dividends to shareholders. The earnings per share
are expected to grow by 10.40 percent yearly over the next five
years.
Market Valuation: Here are the price ratios of the company: The
P/E ratio is 15.32, the P/S ratio is 2.57 and the P/B ratio is
finally 2.12. The dividend yield amounts to 1.10 percent and the
beta ratio has a value of 1.01.
Thermo Fisher Scientific (
TMO
)
has a market capitalization of $22.82 billion. The company employs
39,000 people, generates revenue of $11.73 billion and has a net
income of $1.02 billion. The firm's earnings before interest,
taxes, depreciation and amortization (EBITDA) amounts to $2.11
billion. The EBITDA margin is 17.98 percent (the operating margin
is 10.62 percent and the net profit margin 8.70 percent).
Financial Analysis: The total debt represents 26.19 percent of
the company's assets and the total debt in relation to the equity
amounts to 46.73 percent. Due to the financial situation, a return
on equity of 6.71 percent was realized. Twelve trailing months
earnings per share reached a value of $3.13. Last fiscal year, the
company paid $0.13 in the form of dividends to shareholders. The
earnings per share are expected to grow by 11.36 percent yearly
over the next five years.
Market Valuation: Here are the price ratios of the company: The
P/E ratio is 19.92, the P/S ratio is 1.95 and the P/B ratio is
finally 1.54. The dividend yield amounts to 0.83 percent and the
beta ratio has a value of 0.78.
Take a closer look at the full table of the best healthcare
growth picks. The average price to earnings ratio (P/E ratio)
amounts to 16.51 and forward P/E ratio is 11.91. The dividend yield
has a value of 1.36 percent. Price to book ratio is 3.78 and price
to sales ratio 2.32. The operating margin amounts to 18.28 percent.
The average stock is low leveraged and has a debt to equity ratio
of 0.50.
Selected Articles:
· 20 Of The Biggest Healthcare Dividend Payer
· 12 Healthcare Dividend Stocks With Highest Short Ratio
· The Best Yielding Large Cap Healthcare Dividend Stocks
·
12 Healthcare Dividend Stocks With Gaining Earnings
Momentum